Replies to post #794459 on NorthWest Biotherapeutics Inc (NWBO)

[norisknorewards]

"We are excited to have completed the necessary conditions for closing the acquisition of Advent, and to be moving into position for potential significant scale-up," commented Linda Powers, the Company's CEO. "We believe this integration can also help accelerate development of additional applications and next-generation versions of our technologies, applying the combined expertise and the large portfolio of intellectual property that we have amassed. We believe this represents important progress in building a dominant franchise."

About Northwest

[KRISGO]

thank you Slave1, this is the kind of real news is what we need 😃 not future promises or possibilities, because we’re tired of hearing about things that never actually happen. please take it easy.

[DrHigh]

THANK YOU!

I had my doubts. relieved that my pessimism was proved wrong

[VikingInvest]

I love one word in the PR: "Flaskworks".

[bas2020]

With this closure, NWBO becomes a bonified revenue-generating biotech and will ramp its commercialization with approval... very soon.

With this immediate revenue, we should see far less dilution.

[attilathehunt]

Now that the acquisition is closed, LP can conclude the reduction in pricing for NICE.

One step closer!!!!